SCOPUS 정보 검색 플랫폼

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 12, 2000, Pages 1169-1172

Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol

(5) Panchagnula, R a Agrawal, S a Kaur, K J a Singh, I a Kaul, C L a

a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER (India)

Author keywords

Bio equivalence; Fixed dose combinations; Tuberculosis; WHO IUATLD protocol

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG DOSAGE FORM; HUMAN; HUMAN EXPERIMENT; MEDICAL SOCIETY; NORMAL HUMAN; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL ANALYSIS; TUBERCULOSIS; VOLUNTEER; WORLD HEALTH ORGANIZATION;

ADULT; ANALYSIS OF VARIANCE; ANTIBIOTICS, ANTITUBERCULAR; AREA UNDER CURVE; DRUG EVALUATION; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; RIFAMPIN; SAMPLE SIZE; THERAPEUTIC EQUIVALENCY;

EID: 0034525424 PISSN: 10273719 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (7)

References (10)

1
- 0003424751
- WHO/TB/97/220. Geneva: WHO
- (1997) Treatment of tuberculosis. Guidelines for National Programmes , pp. 25-31
- Maher, D.¹ Chaulet, P.² Spinaci, S.³ Harries, A.D.⁴

2
- 0003441774
- 27 April 1999. WHO/CDS/CPC/TB/99.267. Geneva: WHO Communicable Disease Cluster
- (1999) Fixed-dose combination tablets for the treatment of tuberculosis: Report of an informal meeting held in Geneva , pp. 11-16

3
- 4243265703
- Plan supplies (WHO training modules for TB managers). Global Tuberculosis Program (GTB). Geneva: WHO
- (1996) Managing tuberculosis at national level , pp. 24-25

4
- 0017384056
- Polymorphism of rifampicin
- (1977) Farmaco (Sci) , vol.32 , pp. 471-481
- Pelizza, G.¹ Nebuloni, M.² Ferrari, P.³ Gallo, G.G.⁴

5
- 0018776387
- Public Health Service cooperative trial of three rifampicin-isoniazid regimens in treatment of pulmonary tuberculosis
- (1979) Am Rev Respir Dis , vol.119 , pp. 879-894
- Long, M.W.¹ Snider D.E., Jr.² Farer, L.S.³

6
- 0028338736
- The promise and the reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Program of the World Health Organization
- (1994) Tubercle Lung Dis , vol.75 , pp. 180-181

7
- 0032730490
- Quality assurance: Protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers
- (1999) Int J Tuberc Lung Dis , vol.3 , Issue.SUPPL 3

8
- 0032759650
- The WHO Simplified Study Protocol in practice: Investigation of combined formulations supplied by the WHO
- (1999) Int J Tuberc Lung Dis , vol.3 , Issue.SUPPL 3
- Panchagnula, R.¹ Kaur, K.J.² Singh, I.³ Kaul, C.L.⁴

9
- 0006604729
- Schedule Y: Requirement and guidelines on clinical trials for import and manufacture of new drugs (updated by GSR 588 (E) 2 June 1989) under Drugs and Cosmetic Rules. Delhi: Government of India
- (1945)

10
- 0032956751
- Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method
- (1999) J Pharm Biomed Anal , vol.18 , pp. 1013-1020
- Panchagnula, R.¹ Sood, A.² Sharda, N.³ Kaur, K.⁴ Kaul, C.L.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.